PubMed:34305404 / 1200-1510
Annnotations
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 0-310 | Sentence | denotes | Evidence from experimental models and patients demonstrates widespread expression changes of both P2Y and P2X receptors during epilepsy, and critically, drugs targeting both receptor subtypes, in particular the P2Y1 and P2X7 subtypes, have been shown to possess both anticonvulsive and antiepileptic potential. |
T9 | 0-310 | Sentence | denotes | Evidence from experimental models and patients demonstrates widespread expression changes of both P2Y and P2X receptors during epilepsy, and critically, drugs targeting both receptor subtypes, in particular the P2Y1 and P2X7 subtypes, have been shown to possess both anticonvulsive and antiepileptic potential. |
sonoma
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T35 | 71-81 | MPA | denotes | expression |
T36 | 82-89 | REG | denotes | changes |
T37 | 98-101 | GENE | denotes | P2Y |
T38 | 106-119 | GENE | denotes | P2X receptors |
T39 | 127-135 | DISEASE | denotes | epilepsy |
T40 | 159-168 | REG | denotes | targeting |
T41 | 211-215 | GENE | denotes | P2Y1 |
T42 | 220-224 | GENE | denotes | P2X7 |
T43 | 254-261 | REG | denotes | possess |
T44 | 267-281 | CPA | denotes | anticonvulsive |
T45 | 286-309 | MPA | denotes | antiepileptic potential |
R30 | T35 | T36 | ThemeOf | expression,changes |
R31 | T37 | T35 | ThemeOf | P2Y,expression |
R32 | T37 | T36 | ThemeOf | P2Y,changes |
R33 | T38 | T35 | ThemeOf | P2X receptors,expression |
R34 | T38 | T36 | ThemeOf | P2X receptors,changes |
R35 | T39 | T35 | ThemeOf | epilepsy,expression |
R36 | T39 | T36 | ThemeOf | epilepsy,changes |
R37 | T41 | T40 | ThemeOf | P2Y1,targeting |
R38 | T42 | T40 | ThemeOf | P2X7,targeting |
R39 | T44 | T43 | ThemeOf | anticonvulsive,possess |
R40 | T45 | T43 | ThemeOf | antiepileptic potential,possess |